Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Stopped early · Phase 3

Conditions studied: Type 2 Diabetes Mellitus

In brief

The purpose of this study is to demonstrate the safety and tolerability of dutogliptin over 52 weeks.

Key facts

Study ID

NCT00998686

Run by

Phenomix

People needed

650

Starts

2009-11-01

Expected to finish

2011-11-01

Last updated by the study team

2010-08-11

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completion of all required visits of a qualifying Phase 3 core protocol
• Current treatment of Type 2 diabetes mellitus as in PHX1149-PROT302

You may not qualify if…

• Any condition, disease, disorder or clinically relevant laboratory abnormality which, in the opinion of the investigator, would jeopardize the patient's appropriate participation in this study or obscure the effects of treatment

Where it is running

• Phenomix Investigational Site 105 — Montgomery, Alabama, United States
• Phenomix Investigational Site 121 — Tempe, Arizona, United States
• Phenomix Investigational Site 137 — Tempe, Arizona, United States
• Phenomix Investigational Site 105 — Anaheim, California, United States
• Phenomix Investigational Site 103 — Long Beach, California, United States
• Phenomix Investigational Site 106 — Los Angeles, California, United States
• Phenomix Investigational Site 143 — Coral Gables, Florida, United States
• Phenomix Investigational Site 142 — Hialeah, Florida, United States
• Phenomix Investigational Site 133 — Kissimmee, Florida, United States
• Phenomix Investigational Site 101 — Honolulu, Hawaii, United States
• Phenomix Investigational Site 135 — Chicago, Illinois, United States
• Phenomix Investigational Site 124 — Indianapolis, Indiana, United States
• Phenomix Investigational Site 136 — Brockton, Massachusetts, United States
• Phenomix Investigational Site 138 — Biloxi, Mississippi, United States
• Phenomix Investigational Site 122 — Las Vegas, Nevada, United States
• Phenomix Investigational Site 140 — Las Vegas, Nevada, United States
• Phenomix Investigational Site 110 — Trenton, New Jersey, United States
• Phenomix Investigational Site 116 — Albuquerque, New Mexico, United States
• Phenomix Investigational Site 107 — Winston-Salem, North Carolina, United States
• Phenomix Investigational Site 112 — Greenville, South Carolina, United States
• Phenomix Investigational Site 102 — Dallas, Texas, United States
• Phenomix Investigational Site 104 — San Antonio, Texas, United States
• Phenomix Investigational Site 100 — Kenosha, Wisconsin, United States
• Phenomix Investigational Site 402 — Buenos Aires, Argentina
• Phenomix Investigational Site 408 — Buenos Aires, Argentina

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.